2021
DOI: 10.51847/tcievrcfgf
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of Sildenafil in Pulmonary Hypertension Secondary to Valvular Heart Disease: A Systematic Review and Meta-Analysis

Abstract: Sildenafil is commonly used as off-label medication in Pulmonary Hypertension (PH) secondary to Valvular Heart Disease (VHD). Previously, published systematic review reported the efficacy of sildenafil for PH with VHD specifically in preoperative condition. We conducted this systematic review and meta-analysis to summarize the potential benefits of sildenafil at different treatment phases, namely acute or chronic. Articles available up to June 2020 were identified using Web of Science, Ovid & Medline, EBSCOHOS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Rivaroxaban is taken for three weeks in doses of 15 mg twice daily, then 20 mg once daily. Treatment lasts for six months, but if a temporary major risk factor is present, it may be reduced to three months, or it may last indefinitely there are persistent major risk factors (e.g., cancer, recurrent unprovoked pulmonary embolism) (EINSTEIN-PE Investigators et al, 2012;Ghaffar et al, 2021).…”
Section: Anticoagulationmentioning
confidence: 99%
“…Rivaroxaban is taken for three weeks in doses of 15 mg twice daily, then 20 mg once daily. Treatment lasts for six months, but if a temporary major risk factor is present, it may be reduced to three months, or it may last indefinitely there are persistent major risk factors (e.g., cancer, recurrent unprovoked pulmonary embolism) (EINSTEIN-PE Investigators et al, 2012;Ghaffar et al, 2021).…”
Section: Anticoagulationmentioning
confidence: 99%
“…Ischemic heart disease is defined by decreased cardiac blood flow, which throws off the balance between the oxygen supply and demand in the myocardium [1][2][3]. Most typically, coronary artery disease (CAD), caused by atherosclerotic spasm or blockage of the epicardial coronary arteries, or microvascular dysfunction, is the underlying clinical mechanism.…”
Section: Introductionmentioning
confidence: 99%